Andere talen Cytokinetics, Incorporated

Aandelen

CYTK

US23282W6057

Beurs gesloten - Nasdaq Andere beurzen 22:00:01 23-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
65,57 ^USD	-1,09%		-4,97%	-21,46%

09/04	Insider van Cytokinetics verkocht aandelen ter waarde van $2.422.918, volgens een recent SEC-document	MT
05/04	Sectorupdate: Aandelen in de gezondheidszorg stijgen vrijdagmiddag	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress	10/04
Cytokinetics Insider Sold Shares Worth $2,422,918, According to a Recent SEC Filing	09/04
Sector Update: Health Care Stocks Rise Friday Afternoon	05/04
Cytokinetics Reports Positive Follow-On Data for Prospective Heart Medication; Shares Rise	05/04
Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session	05/04
Cytokinetics Presents Additional 48-Week Data from Forest-Hcm, the Open Label Extension Clinical Study of Aficamten, At the American College of Cardiology 73rd Annual Scientific Session	05/04
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	02/04
Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference	01/04
Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session	25/03
Cytokinetics, Incorporated(NasdaqGS:CYTK) added to S&P 400 - Biotechnology	18/03
Cytokinetics, Incorporated(NasdaqGS:CYTK) added to S&P 400 Health Care	18/03
Cytokinetics, Incorporated(NasdaqGS:CYTK) added to S&P 400	18/03
Cytokinetics, Incorporated(NasdaqGS:CYTK) dropped from S&P 600	18/03
Cytokinetics, Incorporated(NasdaqGS:CYTK) dropped from S&P 600 Health Care	18/03
Cytokinetics to Participate in March Investor Conferences	04/03
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	01/03
Cytokinetics Joins Global Initiative to Recognize International Rare Disease Day	29/02
Cytokinetics, The Mended Hearts, Inc. and WomenHeart Announce Launch of New Initiative to Increase Engagement in Cardiovascular Clinical Trials	28/02
Cytokinetics Q4 Net Loss Narrows, Revenue Decreases; 2024 Outlook Issued	27/02
Cytokinetics: Q4 Earnings Snapshot	27/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Cytokinetics, Incorporated

Aandelen

CYTK

US23282W6057

Andere talen

Filters